SRX Global Updates Engineered T-Cell Strategy After Pfizer-Starna Licensing Agreement
SRX Global provided an update on its engineered T-cell strategy following a Pfizer-Starna licensing agreement. The available body text is truncated.
SRX Global provided an update on its engineered T-cell strategy following a Pfizer-Starna licensing agreement. The available body text is truncated.